Default: Lancet Respiratory Medicine,The

ISSN: 2213-2619

Journal Home

Journal Guideline

Lancet Respiratory Medicine,The Q1 Unclaimed

Elsevier Ltd. United Kingdom
Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Lancet Respiratory Medicine,The is a journal indexed in SJR in Pulmonary and Respiratory Medicine with an H index of 113. It has an SJR impact factor of 9,03 and it has a best quartile of Q1. It has an SJR impact factor of 9,03.

Lancet Respiratory Medicine,The focuses its scope in these topics and keywords: pulmonary, chronic, randomised, obstructive, idiopathic, fibrosis, disease, finlanda, exacerbations, doubleblind, ...

Type: Journal

Type of Copyright:

Languages:

Open Access Policy:

Type of publications:

Publication frecuency: -

Price

- €

Inmediate OA

NPD

Embargoed OA

- €

Non OA

Metrics

Lancet Respiratory Medicine,The

9,03

SJR Impact factor

113

H Index

330

Total Docs (Last Year)

813

Total Docs (3 years)

5300

Total Refs

5271

Total Cites (3 years)

247

Citable Docs (3 years)

6,76

Cites/Doc (2 years)

16,06

Ref/Doc

Comments

No comments ... Be the first to comment!

Aims and Scope


pulmonary, chronic, randomised, obstructive, idiopathic, fibrosis, disease, finlanda, exacerbations, doubleblind, diagnosisoncedaily, degradation, cromoglicate, cough, formulation, girl, guidancethe, health, identify, indacaterol, indian, influenza, inhaled, copdlandmark, controlled, assessment, asthma, asthmachildhood, bedaquiline, biomarkers, blinded, burden, call, cessation, change, classification, cleaning, collagen, comprehensive, consultations,

FAQS